Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingming Deng

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 3, 2017
Targeting miR-21 with Sophocarpine Inhibits Tumor Progression and Reverses Epithelial-Mesenchymal Transition in Head and Neck CancerWei Liu, Beilei Zhang, Guo Chen, et al.
Molecular Cancer|April 12, 2019
Small Molecule KRAS Agonist for Mutant KRAS Cancer TherapyKe Xu, Dongkyoo Park, Andrew T Magis, et al.
Molecular Cancer|May 22, 2020
Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer TherapyKe Xu, Dongkyoo Park, Andrew T Magis, et al.
Plos One|September 11, 2013
Inhibition of STAT3 by niclosamide synergizes with erlotinib against head and neck cancerRui Li, Shuo You, Zhongliang Hu, et al.
Oncotarget|April 7, 2016
BCL2-BH4 antagonist BDA-366 suppresses human myeloma growthJiusheng Deng, Dongkyoo Park, Mengchang Wang, et al.
International Journal of Oncology|September 18, 2013
EBV-LMP1-targeted DNAzyme induces DNA damage and causes cell cycle arrest in LMP1-positive nasopharyngeal carcinoma cellsXiaoqian Ma, Zhijie Xu, Lifang Yang, et al.
Neoplasia (New York, N.Y.)|January 12, 2013
c-Myc suppression of DNA double-strand break repairZhaozhong Li, Taofeek K Owonikoko, Shi-Yong Sun, et al.
The Journal of Biological Chemistry|March 29, 2013
Protein phosphatase 2A and DNA-dependent protein kinase are involved in mediating rapamycin-induced Akt phosphorylationYikun Li, Xuerong Wang, Ping Yue, et al.
Plos One|August 27, 2013
The function and significance of SELENBP1 downregulation in human bronchial epithelial carcinogenic processGu-Qing Zeng, Hong Yi, Peng-Fei Zhang, et al.
Molecular Cancer Therapeutics|July 30, 2013
Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancerRui Li, Zhongliang Hu, Shi-Yong Sun, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 3, 2017
Targeting miR-21 with Sophocarpine Inhibits Tumor Progression and Reverses Epithelial-Mesenchymal Transition in Head and Neck CancerWei Liu, Beilei Zhang, Guo Chen, et al.
Molecular Cancer|April 12, 2019
Small Molecule KRAS Agonist for Mutant KRAS Cancer TherapyKe Xu, Dongkyoo Park, Andrew T Magis, et al.
Molecular Cancer|May 22, 2020
Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer TherapyKe Xu, Dongkyoo Park, Andrew T Magis, et al.
Plos One|September 11, 2013
Inhibition of STAT3 by niclosamide synergizes with erlotinib against head and neck cancerRui Li, Shuo You, Zhongliang Hu, et al.
Oncotarget|April 7, 2016
BCL2-BH4 antagonist BDA-366 suppresses human myeloma growthJiusheng Deng, Dongkyoo Park, Mengchang Wang, et al.
International Journal of Oncology|September 18, 2013
EBV-LMP1-targeted DNAzyme induces DNA damage and causes cell cycle arrest in LMP1-positive nasopharyngeal carcinoma cellsXiaoqian Ma, Zhijie Xu, Lifang Yang, et al.
Neoplasia (New York, N.Y.)|January 12, 2013
c-Myc suppression of DNA double-strand break repairZhaozhong Li, Taofeek K Owonikoko, Shi-Yong Sun, et al.
The Journal of Biological Chemistry|March 29, 2013
Protein phosphatase 2A and DNA-dependent protein kinase are involved in mediating rapamycin-induced Akt phosphorylationYikun Li, Xuerong Wang, Ping Yue, et al.
Plos One|August 27, 2013
The function and significance of SELENBP1 downregulation in human bronchial epithelial carcinogenic processGu-Qing Zeng, Hong Yi, Peng-Fei Zhang, et al.
Molecular Cancer Therapeutics|July 30, 2013
Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancerRui Li, Zhongliang Hu, Shi-Yong Sun, et al.
Pageof 10